Investigation of Vietnamese plants for potential anticancer agents

Phytochemistry Reviews

Volumn 13, Issue 4, 2014, Pages 727-739

  Bueno Pérez, Lynette ^a   Still, Patrick C ^a   Naman, C Benjamin ^a   Ren, Yulin ^a   Pan, Li ^a   Chai, Hee Byung ^a   Carcache de Blanco, Esperanza J ^a   Ninh, Tran Ngoc ^b   Van Thanh, Bui ^b   Swanson, Steven M ^c   Soejarto, Djaja D ^c,d   Kinghorn, A Douglas ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b INSTITUTE OF ECOLOGY AND BIOLOGICAL RESOURCES   (Viet Nam)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d FIELD MUSEUM OF NATURAL HISTORY   (United States)

Author keywords

Anticancer agents; Natural products; Tropical plants; Vietnam

Indexed keywords

(6ABETA,12ABETA) HYDROXYROTENONE; 2,3 DIHYDROTEPHROAPOLLIN C; 2,3 DIHYDROTEPHROGLABRIN; 25 O ACETYLCUCURBITACIN F; 3 EPI ISOCUCURBITACIN D; 5 METHOXYPURPURIN; ALPHA AMANGOSTIN; ANTINEOPLASTIC AGENT; BARBATUMOL A; BRUCEANTIN; BRUCEINE A; CHALCONE DERIVATIVE; COCHINCHINOXANTHONE; CUCURBITACIN D; CUCURBITACIN I; ELAEOCARPUCIN C; FLAVANONE; FLAVONOLIGNAN; HYDNOCARPIN; METHYLROCAGLATE; MICROGREWIAPINE A; PERVIRIDISIN B; PLANT MEDICINAL PRODUCT; ROCAGLAOL; ROTENONE; TEPHROPURPURI; TEPHROSIN; TEPHROSONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

AGLAIA PERVIRIDIS; ANTIDESMA BUNIUS; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BOTANY; BRUCEA JAVANICA; CRATOXYLUM COCHINCHINENSE; CYTOTOXICITY; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; ELAEOCARPUS CHINENSIS; HUMAN; INDIGOFERA SPICATA; MEDICINAL PLANT; MICROCOS PANICULATA; NONHUMAN; PHYTOCHEMISTRY; PIPER SARMENTOSUM; REVIEW; VIET NAM;

EID: 84911998082     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-014-9335-7     Document Type: Review

References (47)

1. Abd El-Razek MH, Mohamed AE-HH, Ahmed AA (2007) Prenylated flavonoids from Tephrosia apollinea. Heterocycles 71:2477–2490
2. American Cancer Society (2013). Cancer facts & figures 2013. Atlanta: American Cancer Society. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed Sept 2013
3. Appendino G, Fontana G, Pollastro F (2010) Natural products drug discovery. In: Verpoorte R (ed) Comprehensive natural products chemistry II, vol 3. Elsevier, Oxford, UK, pp 205–236
4. Bailly C (2009) Ready for a comeback of natural products in oncology. Biochem Pharmacol 77:1447–1457
5. Bueno Pérez L, Pan L, Sass EJ, Gupta SV, Lehman A, Kinghorn AD, Lucas DM (2012) Potentiating effect of the flavonolignan (−)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell line. Phytother Res. doi:10.1002/ptr.4903
6. Bueno Pérez L, Li J, Lantvit DD, Pan L, Ninh TN, Chai H-B, Soejarto DD, Swanson SM, Lucas DM, Kinghorn AD (2013) Bioactive constituents of Indigofera spicata. J Nat Prod 76:1498–1504
7. Chen ST, Dou J, Temple R, Agarwal R, Wu K-M, Walker S (2008) New therapies from old medicines. Nat Biotechnol 26:1077–1083
8. Cragg GM, Grothaus PG, Newman DJ (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043
9. Deng Y, Balunas MJ, Kim J-A, Lantvit DD, Chin Y-W, Chai H-B, Sugiarso S, Kardono LBS, Fong HHS, Pezzuto JM, Swanson SM, Carcache de Blanco EJ, Kinghorn AD (2009) Bioactive 5,6-dihydro-α-pyrone derivatives from Hyptis brevipes. J Nat Prod 72:1165–1169
10. Dou J (2013) Botanical new drugs: from INDs to NDAs. Presentation at the 54th Annual Meeting of the American Society of Pharmacognosy, St. Louis, MO. Planta Med 79:836
11. El-Elimat T, Zhang X, Jarjoura D, Moy FJ, Orjala J, Kinghorn AD, Pearce CJ, Oberlies NH (2012) Chemical diversity of metabolites from fungi, cyanobacteria, and plants relative to FDA-approved anticancer agents. ACS Med Chem Lett 3:645–649
12. Feher M, Schmidt JM (2003) Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43:218–227
13. Gatti L, Zuco V, Zaffaroni N, Perego P (2013) Drug combinations with proteasome inhibitors in antitumor therapy. Curr Pharm Des 19:4094–4114
14. Gordaliza M (2007) Natural products as leads to anticancer drugs. Clin Transl Oncol 9:767–776
15. Inada A, Sorano T, Murata H, Inatomi Y, Darnaedy D, Nakanishi T (2001) Diamide derivatives and cycloartanes from the leaves of Aglaia elliptica. Chem Pharm Bull 49:1226–1228
16. Kim HJ, Hawke N, Baldwin AS (2006) NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ 13:738–747
17. Kinghorn AD, Carcache de Blanco EJ, Chai H-B, Orjala J, Farnsworth NR, Soejarto DD, Oberlies NH, Wani MC, Kroll DJ, Pearce CJ, Swanson SM, Kramer RA, Rose WC, Fairchild CR, Vite GD, Emanuel S, Jarjoura D, Cope FO (2009) Discovery of anticancer agents of diverse natural origin. Pure Appl Chem 81:1051–1063
18. Kinghorn AD, Pan L, Fletcher JN, Chai H-B (2011) The relevance of higher plants in lead compound discovery programs. J Nat Prod 74:1539–1555
19. Kingston DGI (2011) Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod 74:496–511
20. Kingston DGI, Tamarkin L, Paciotti GF (2012) Conformationally constrained and nanoparticle-targeted paclitaxels. Pure Appl Chem 84:1455–1467
21. Lachance H, Wetzel S, Kumar K, Waldmann H (2012) Charting, navigating, and populating natural product chemical space for drug discovery. J Med Chem 55:5989–6001
22. Loub WD, Farnsworth NR, Soejarto DD, Quinn ML (1985) NAPRALERT: computer handling of natural product research data. J Chem Inform Comp Sci 25:99–103
23. Lucas DM, Still PC, Bueno Perez L, Grever MR, Kinghorn AD (2010) Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Curr Drug Targets 11:812–822
24. Malcolm JR, Liu C, Neilson RP, Hansen L, Hannah L (2006) Global warming and extinctions of endemic species from biodiversity hotspots. Conserv Biol 20:538–548
25. Matthew S, Pan L, Shen Q, Kinghorn AD, Swanson SM, Carcache de Blanco EJ (2011) Dichamanetin, a C-benzylated flavonoid from Piper sarmentosum inhibits cell growth and induces G1 cell cycle arrest in cancer cells through mitochondrial-mediated apoptosis. Presentation at the 102nd Annual Meeting of the American Association of Cancer Research, Orlando, FL, April 2–April 6
26. Mi Q, Pezzuto JM, Farnsworth NR, Wani MC, Kinghorn AD, Swanson SM (2009) Use of the in vivo hollow fiber assay in natural products drug discovery. J Nat Prod 72:573–580
27. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
28. Newman DJ, Giddings L-A (2013) Natural products as leads to antitumor drugs. Phytochem Rev. doi:10.1007/s111-013-9292-6
29. Orjala J, Oberlies NH, Pearce CJ, Swanson SM, Kinghorn AD (2012) Discovery of potential anticancer agents from aquatic cyanobacteria, filamentous fungi, and tropical plants. In: Tringali C (ed) Bioactive compounds from natural sources, natural products as lead compounds in drug discovery, 2nd edn. Taylor & Francis, London, pp 37–63
30. Pan L, Chin Y-W, Chai H-B, Ninh TN, Soejarto DD, Kinghorn AD (2009) Activity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam. Bioorg Med Chem 17:2219–2224;
31. Pan L, Matthew S, Chai H-B, Ninh TN, Kleinholz NM, Green-Church KB, Soejarto DD, Carcache de Blanco EJ, Kinghorn AD (2011a) Isolation and analysis of aristolochic acid I and other compounds from the roots and other plant parts of Antidesma bunius. Presentation at the 52nd Annual Meeting of the American Society of Pharmacognosy, San Diego, CA, July 30–Aug 3
32. Pan L, Matthew S, Lantvit DD, Zhang X, Ninh TN, Chai H-B, Carcache de Blanco EJ, Soejarto DD, Swanson SM, Kinghorn AD (2011b) Bioassay-guided isolation of constituents of Piper sarmentosum using a mitochondrial transmembrane potential assay. J Nat Prod 74:2193–2199
33. Pan L, Chai H-B, Kinghorn AD (2012a) Discovery of new anticancer agents from higher plants. Front Biosci (Schol Ed) 4:142–156
34. Pan L, Yong Y, Muñoz Acuña U, Deng Y, Lantvit DD, Ninh TN, Chai H-B, Carcache de Blanco EJ, Soejarto DD, Swanson SM, Kinghorn AD (2012b) Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents of Elaeocarpus chinensis. J Nat Prod 75:444–452
35. Pan L, Muñoz Acuña U, Li J, Jena N, Ninh TN, Pannell CM, Chai H-B, Fuchs JR, Carcache de Blanco EJ, Soejarto DD, Kinghorn AD (2013) Bioactive flavaglines and other constituents isolated from Aglaia perviridis. J Nat Prod 76:394–404
36. Pearce CJ, Lantvit DD, Shen Q, Jarjoura D, Zhang X, Oberlies NH, Kroll DJ, Wani MC, Orjala J, Soejarto DD, Farnsworth NR, Carcache de Blanco EJ, Fuchs JR, Kinghorn AD, Swanson SM (2012) Use of the hollow fiber assay for discovery of novel anticancer agents from fungi. In: Keller N, Turner G (eds) Fungal secondary metabolism: methods and protocols, vol 944., Humana Press/SpringerTotowa, NJ, pp 267–277
37. Rahier NJ, Thomas CJ, Hecht SM (2005) Camptothecin and its analogs. In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. CRC Taylor & Francis, Boca Raton, pp 5–21
38. Rai PK, Lalramnghinglova H (2011) Threathened and less known ethnomedicinal plants of an Indo-Burma hotspot region: conservation implications. Environ Monit Assess 178:53–62
39. Rao EV, Raju NR (1984) Two flavonoids from Tephrosia purpurea. Phytochemistry 23:2339–2342
40. Ren Y, Lantvit DD, Carcache de Blanco EJ, Kardono LBS, Riswan S, Chai H-B, Cottrell CE, Farnsworth NR, Swanson SM, Ding Y, Li XC, Marais JPJ, Ferreira D, Kinghorn AD (2010) Proteasome-inhibitory and cytotoxic constituents of Garcinia lateriflora: absolute configuration of caged xanthones. Tetrahedron 66:5311–5320
41. Ren Y, Matthew S, Lantvit DD, Ninh TN, Chai H-B, Fuchs JR, Soejarto DD, Carcache de Blanco EJ, Swanson SM, Kinghorn AD (2011) Cytotoxic and NFkB inhibitory constituents of the stems of Cratoxylum cochinchinense and their semi-synthetic analogues. J Nat Prod 74:1117–1125
42. Siegel R, Naishadham D (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
43. Spear SA, Burns SS, Oblinger JL, Ren Y, Pan L, Kinghorn AD, Welling DB, Chang LS (2013) Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide. Otol Neurotol 34:1519–1527
44. Still PC, Yi B, González Muskus T, Pan L, Pavlovicz R, Chai H-B, Ninh TN, Li C, Soejarto DD, McKay D, Kinghorn AD (2013) Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities. J Nat Prod 76:243–249
45. Thoison O, Fahy J, Dumontet V, Chiaroni A, Riche C, Tri MV, Sévenet T (2000) Cytotoxic prenylxanthones from Garcinia bracteata. J Nat Prod 63:441–446
46. Waterman PG, Khalid SA (1980) The major flavonoids of the seed of Tephrosoa apollinea. Phytochemistry 19:909–915
47. Zhang Y, Talalay P, Cho C-G, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 89:2399–2403